The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG

MLA

Qi-Dong Xia, et al. “The Role of TERT C228T and KDM6A Alterations and TME in NMIBC Treated with BCG.” Npj Precision Oncology, vol. 8, no. 1, Oct. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41698-024-00725-4.

APA

Qi-Dong Xia, Jian-Xuan Sun, Zhi-Peng Yao, Jun-Lin Lu, Chen-Qian Liu, Jin-Zhou Xu, Ye An, Meng-Yao Xu, Si-Han Zhang, Xing-Yu Zhong, Na Zeng, Si-Yang Ma, Hao-Dong He, Heng-Long Hu, Jia Hu, Yi Lu, Bing Li, Yao-Bing Chen, Zheng Liu, & Shao-Gang Wang. (2024). The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG. Npj Precision Oncology, 8(1), 1–13. https://doi.org/10.1038/s41698-024-00725-4

Chicago

Qi-Dong Xia, Jian-Xuan Sun, Zhi-Peng Yao, Jun-Lin Lu, Chen-Qian Liu, Jin-Zhou Xu, Ye An, et al. 2024. “The Role of TERT C228T and KDM6A Alterations and TME in NMIBC Treated with BCG.” Npj Precision Oncology 8 (1): 1–13. doi:10.1038/s41698-024-00725-4.